23948sdkhjf
  1. Udbud
  2. Social og sundhedsvæsen
  3. Lægemidler

Fakta om udbudet

EU-nr
2019/S 177-430946
Offentliggjort
13.09.2019
Udbudstype
Tildeling af kontrakt uden forudgående offentliggørelse

Udbyder

Kungliga Tekniska högskolan

Vindere

(13.09.2019)
10x Genomics
2316 XC Leiden

Procurement of 10X Genomics Visium kits

Kungliga Tekniska högskolan

Voluntary ex ante transparency notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1) Name and addresses
Kungliga Tekniska högskolan
202100-3054
Teknikringen 50, plan 3
Stockholm
100 44
Sweden
Contact person: Kicki Holmberg
E-mail: hoki@kth.se
NUTS code: SE11

Internet address(es):

Main address: http://www.kth.se

I.4) Type of the contracting authority
National or federal agency/office
I.5) Main activity
Education

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Procurement of 10X Genomics Visium kits

Reference number: C-2019-1688
II.1.2) Main CPV code
33696500
II.1.3) Type of contract
Supplies
II.1.4) Short description:

Part of NGI Stockholms mission as a state-of-the-art facility is making novel techniques available to the research community. Due to this, NGI is now planning to start running the spatial transcriptomics method which enables spatially resolved RNA expression data to be collected from tissue sections. This method uses kits sold under the brand name Visium to be purchased from 10x genomics as they currently are the only provider of these kits.

II.1.6) Information about lots
This contract is divided into lots: no
II.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: 58 000.00 USD
II.2) Description
II.2.1) Title:
II.2.2) Additional CPV code(s)
II.2.3) Place of performance
NUTS code: SE110
Main site or place of performance:

Scilifelab, Tomtebodavägen 23, Solna.

II.2.4) Description of the procurement:

Part of NGI Stockholms mission as a state-of-the-art facility is making novel techniques available to the research community. Due to this, NGI is now planning to start running the spatial transcriptomics, enabling global assessment of RNA expression in a spatially resolved manner along the area of a tissue section. Briefly, RNA molecules expressed at thousands of spatially defined coordinates in the tissue are subject to cDNA syntesis using oligonucleotides carrying coordinate specific sequence motifs. It is known which sequence motifs correspond to which coordinate and this enables spatially resolved RNA expression levels to be determined after sequencing the synthesized cDNA. This method uses kits sold under the brand name ‘Visium Spatial’ to be purchased from 10x genomics as they currently are the only provider of a solution enabling transciptome-wide, non-targeted spatial transciptomics.

II.2.5) Award criteria
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information

Section IV: Procedure

IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
  • The procurement falls outside the scope of application of the directive
Explanation:

The Visium spatial kits from 10x genomics are intended to be introduced in the operations at NGI Stockholm in a pilot phase to investigate the utility of this technology developed by the company. There are other companies offering products for spatial transcriptomics inference but their products offer targeted assays targeting a subset of distinct RNA. This stands in contrast to the Visium spatial solution by 10X genomics as Visium enables global expression inference any poly-adenlylated mRNA. The reagent kits required are solely provided by 10x genomics as they are protected by patents (US Pat. No 10,030,261, US Pat No 9,593,365, US Pat No 9,371,598, US Pat No 10,308,982, US Pat No 9,868,979 and US Pat No 9,879,313) and no alternatives are thus available on the market.

IV.1.3) Information about framework agreement
IV.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure

Section V: Award of contract/concession

V.2) Award of contract/concession
V.2.1) Date of contract award decision:
11/09/2019
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators: no
V.2.3) Name and address of the contractor/concessionaire
10x Genomics
45-5614458
Leiden
2316 XC
Netherlands
Telephone: +31 208886622
NUTS code: NL33
The contractor/concessionaire will be an SME: yes
V.2.4) Information on value of the contract/lot/concession (excluding VAT)
Initial estimated total value of the contract/lot/concession: 58 000.00 USD
Total value of the contract/lot/concession: 58 000.00 USD
V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information:

Visma notice: https://opic.com/id/afjtwxvgsj

VI.4) Procedures for review
VI.4.1) Review body
Förvaltningsrätten i Stockholm
Stockholm
Sweden
VI.4.2) Body responsible for mediation procedures
VI.4.3) Review procedure
VI.4.4) Service from which information about the review procedure may be obtained
VI.5) Date of dispatch of this notice:
11/09/2019

Send til en kollega

0.047